Central Administration

Keyphrases

1. Lactate 100%
2. Glutamate 86%
3. Antimicrobial Resistance 80%
4. Antimicrobial 67%
5. Parkinson Patients 63%
6. Bradykinesia 63%
7. Glutamine 57%
8. Solid State 56%
9. Astrocytic 56%
10. Homeostasis 56%
11. Astrocytes 55%
12. Developing Countries 51%
13. Europe 47%
14. Parkinson's Disease 42%
15. Human Health 42%
16. Ribotyping 42%
17. Motor Symptoms 42%
18. Food Animals 42%
19. Molecular Electronics 42%
20. Human Isolates 40%
21. Glycogen 39%
22. Top Contact 37%
23. Aglycemia 37%
24. Orthopedic Surgery 37%
25. GABAergic 37%
26. Room Temperature 37%
27. Conductance 37%
28. Risk Analysis 35%
29. Energy Substrates 35%
30. Neurotransmitters 33%
31. Order of Magnitude 33%
32. Glutamatergic Neurons 30%
33. Day Case 28%
34. Device Engineering 28%
35. Materials Science Engineering 28%
36. Explanatory Text 28%
37. Low-energy Diet 28%
38. Gait Assessment 28%
39. Diabetes Mellitus Patients 28%
40. S. Hyicus 28%
41. α-amylase 28%
42. Transversal 28%
43. Nutritional Condition 28%
44. Researcher Identity 28%
45. Online News 28%
46. Pre-diabetes (pre-DM) 28%
47. Developing World 28%
48. Gold Nanoparticles 28%
49. Antimicrobial-resistant Bacteria 28%
50. Listeria Monocytogenes 28%
51. Neutron Reflectivity 28%
52. Phenotypic Methods 28%
53. Brain Glycogen 28%
54. Quantum Interference 28%
55. Nomadic Device 28%
56. Device Adaptation 28%
57. Graph Representation 28%
58. Compound Action Potential 28%
59. Parkinson's Disease Diagnosis 28%
60. Oligo(phenyleneethynylene) 28%
61. Public Health 28%
62. Aleurone 28%
63. Genotypic Methods 28%
64. Single Molecule Level 28%
65. Pharmacological Tools 28%
66. Nanoparticle Growth 28%
67. Animal Growth 28%
68. Infantis 28%
69. Nanofabrication 28%
70. Fiscal Outcomes 28%
71. Automatic Assessment 28%
72. Pulsed-field Gel Electrophoresis 28%
73. Denmark 28%
74. Antimicrobial Growth Promoters 28%
75. Foodborne Zoonoses 28%
76. Coding Region 28%
77. Patient Assessment 28%
78. Glutamate Transport 28%
79. Weight Load 28%
80. Home Environment 28%
81. Serovars 28%
82. Protein Kinase 28%
83. Rat Model 28%
84. Salmonella Enterica 28%
85. Management System 28%
86. Risk Management 28%
87. Patient Satisfaction 28%
88. Barley 28%
89. Action Disorganization Syndrome 28%
90. Intervention Studies 28%
91. Spatial Scan Statistic 28%
92. Ultrathin 28%
93. Electronic Junction 28%
94. Graphene Film 28%
95. Husbandry 28%
96. NMR Spectroscopy 28%
97. Epidemiological Typing 28%
98. MRNA Level 28%
99. Profilers 28%
100. Enterica 28%